Isoniemi H, Koivusalo A-M, Repo H, Ilonen I, Höckerstedt K
Transplantation and Liver Surgery Clinic and Department of Medicine, Helsinki University Hospital, Helsinki, Finland.
Transplant Proc. 2005 Mar;37(2):1088-90. doi: 10.1016/j.transproceed.2004.11.060.
In acute liver failure (ALF), detoxification capacity of liver cells is reduced and a variety of cytokines, immune modulators, and toxic substances are accumulating. Multiple organ failure in ALF has been associated with increased blood cytokine levels. We have used a blood purification system, molecular adsorbent recirculating system (MARS), which is based on removal of both protein bound and water-soluble substances and toxins in liver failure. In this study, we measured the effect of MARS therapy on plasma cytokine levels in 49 patients with ALF. Interleukin 6 (IL-6), IL-8, IL-10 and tumor necrosis factor (TNF)alfa were determined immediately before and after the first MARS therapy and after the last session using enzyme-linked immunosorbent assays. The overall survival of these ALF patients was 82% at 6 months; the native liver recovered in 26 cases, and 14 were successfully transplanted. All three interleukins were increased before the MARS treatment but only anti-inflammatory IL-10 was reduced significantly during therapy, which in this setting could be interpreted as a positive effect. We were not able to show constant decreases in proinflammatory cytokines, but only transient effects on IL-8 and IL-6. Surprisingly TNFalfa level was normal and did not change during therapy. In theory, MARS albumin dialysis may remove toxic substances from the blood circulation and thereby improve the possibilities of the liver to recover; however, of the measured cytokines only IL-10 decreased significantly.
在急性肝衰竭(ALF)中,肝细胞的解毒能力降低,多种细胞因子、免疫调节剂和有毒物质不断积累。ALF中的多器官衰竭与血液中细胞因子水平升高有关。我们使用了一种血液净化系统,即分子吸附循环系统(MARS),该系统基于清除肝衰竭中与蛋白结合的物质、水溶性物质和毒素。在本研究中,我们测量了MARS治疗对49例ALF患者血浆细胞因子水平的影响。在首次MARS治疗前、首次治疗后及最后一次治疗后,采用酶联免疫吸附测定法测定白细胞介素6(IL-6)、IL-8、IL-10和肿瘤坏死因子(TNF)α。这些ALF患者6个月时的总体生存率为82%;26例患者的天然肝脏恢复,14例成功接受移植。在MARS治疗前,所有三种白细胞介素均升高,但在治疗期间只有抗炎性IL-10显著降低,在这种情况下可将其解释为一种积极效果。我们未能显示促炎细胞因子持续降低,仅对IL-8和IL-6有短暂影响。令人惊讶的是,TNFα水平正常,且在治疗期间未发生变化。理论上,MARS白蛋白透析可从血液循环中清除有毒物质,从而提高肝脏恢复的可能性;然而,在所测量的细胞因子中,只有IL-10显著降低。